L-tryptophan supplementation for celiac disease symptoms
Official title: Restoration of Impaired Microbiota-mediated Aryl Hydrocarbon Receptor Signaling in Celiac Disease by Oral Tryptophan Supplementation: an Exploratory, Pilot Trial
Run by McMaster University · NCT05576038 · Data updated 2026-11-12
This study is testing if taking L-tryptophan can help people with celiac disease who still have symptoms after a year on a gluten-free diet feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | McMaster University Academic / other |
| Locations | 1 site (Hamilton, Ontario) |
| Status | Recruiting |
| Started | December 1, 2022 |
| Main results expected | April 1, 2025 |
| Study ends | June 1, 2025 |
| Registry record updated | January 10, 2025 |
| Trial ID | NCT05576038 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 75 with biopsy-confirmed celiac disease and persistent symptoms despite a gluten-free diet.
✕Probably not a fit
Patients with concurrent gastrointestinal diseases or those on certain medications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial evaluates the effects of L-tryptophan supplementation on individuals with biopsy-confirmed celiac disease who continue to experience symptoms despite following a gluten-free diet for over a year. Fifty participants aged 18 to 75 will be randomly assigned to receive either L-tryptophan or a placebo for three weeks. Participants will also receive dietary counseling to maintain a low tryptophan, gluten-free diet, and their compliance will be monitored through dietary recalls. The study will assess symptom changes and collect various biological samples to understand the impact of the intervention.
Why it matters
Potential benefit: If successful, this study could provide a new dietary intervention for patients with celiac disease who do not respond to a gluten-free diet.
How similar studies have gone: While the approach of using L-tryptophan supplementation is novel, similar dietary interventions have shown promise in other gastrointestinal conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * 18 and 75 years of age * Celiac disease (CeD) diagnosis: Individuals with histological and serological evidence of CeD serology (positive biopsy and anti-tTG IgA) * Persistent CeD related symptoms (\>40 on the Celiac Symptom Index) despite \>1 year of a gluten free diet (GFD) Exclusion criteria: * Acid anti-secretory and antacid medications * Antibiotics, antibacterial agents or probiotics, currently, or within the last 8 weeks * Current organic gastrointestinal or other autoimmune diseases, such as inflammatory bowel disease or diabetes mellitus (type 1) * Lactose and/or fructose intolerance * History of bariatric surgery, fundoplication or gastrectomy (partial or complete) * Connective tissue disease * Concurrent organic GI pathology other than benign polyps, haemorrhoids, lipomas, Helicobacter pylori infection, diverticulosis and melanosis coli * Chronic treatment with high dose opioids * Alcohol or drug abuse * Concurrent systemic disease and/or laboratory abnormalities considered by investigators to be a risk or that could interfere with data collection * Allergy or sensitivity to any component of the study medication or placebo * Use of lithium and monoamine oxidase inhibitors (MAOIs) * Participation in another dietary treatment study within the last 4 weeks
Where it's running
-
McMaster University
Hamilton, Ontario, Canada Recruiting
Study contacts
- Study coordinator: Gaston H Rueda, MD
- Email: ruedag@mcmaster.ca
- Phone: 905 521-2100
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mediterranean diet and processed food in adults with celiac disease on a gluten-free diet
This observational study looks at whether following a Mediterranean-style diet or eating more highly processed foods affects GI symptoms and quality of life in adults with celiac disease who have been on a strict gluten-free diet.
-
Exercise for Metabolic Syndrome and Fatty Liver in Adolescent Girls with Celiac Disease
This study tests whether a 3-month walking program helps improve metabolic syndrome and fatty liver in adolescent females with celiac disease.
-
Nutrition and physical activity education for children with celiac disease
This study tests whether a combined nutrition and physical activity education program helps 8- to 12-year-olds with celiac disease improve body health, eating habits, activity, and quality of life while on a gluten-free diet.
-
Liver Fat and Scarring in People Suspected of Non-Celiac Wheat Sensitivity
This study looks to see if people with non-celiac wheat sensitivity have liver fat or fibrosis and how this relates to IBS/FD and celiac disease.
-
Omega-3 fats to reduce inflammation in adults with newly diagnosed celiac disease
This study tests whether adding omega-3 fatty acid supplements to a gluten-free plan helps reduce inflammation and promote intestinal healing in adults who have just been diagnosed with celiac disease.
-
Wheat sensitivity or IBS/functional dyspepsia in relatives of people with celiac disease
This project will test whether adults related to celiac patients have higher rates of non-celiac wheat sensitivity or IBS/functional dyspepsia and whether symptoms change on a wheat-free diet.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.